Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 13(1): 4885, 2023 03 25.
Article in English | MEDLINE | ID: mdl-36966208

ABSTRACT

Visual-related quality of life in retinal diseases has not been explored in the Mexican population, so the study aims to identify it in patients undergoing surgery due to advanced diabetic retinopathy, rhegmatogenous retinal detachment, and other causes of vitrectomy; the Visual Function Quality-25 questionnaire was applied to 76 patients, pre-and postoperative. It was divided into 10 domains and interpreted according to the National Eye Institute scores, where the highest value was the best visual function. Student's t-test for related samples and Wilcoxon's t-test were used to compare each domain between measurements, and Pearson's R test to correlate the total score of age and quality of life; a p value < 0.05 was considered significant. Diabetic retinopathy patients showed an improvement 1 and 3 months after surgery in all domains; in rhegmatogenous retinal detachment, there was an improvement observed up to 3 months, while a decrease in ocular pain was observed in other causes of vitrectomy. Differences found in all the quality-of-life scores were not statistical, but clinically significant. The study shows that visual-related quality of life domains improves after vitrectomy; the inclusion of this analysis might be considered relevant within the parameters of surgical success of the most prevalent vitreoretinal diseases.


Subject(s)
Diabetic Retinopathy , Retinal Detachment , Retinal Diseases , Humans , Quality of Life , Diabetic Retinopathy/complications , Visual Acuity , Vitrectomy/adverse effects , Retrospective Studies
2.
Infection ; 51(3): 765-768, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36630044

ABSTRACT

PURPOSE: The relationship of Helicobacter pylori infection with ocular diseases, including anterior uveitis, has been reported. The objective of this study was to determine the presence of anti-H. pylori IgG antibodies in patients with idiopathic non-granulomatous anterior uveitis and compare the results with a control group. METHODS: A prospective, comparative, and cross-sectional study was conducted. Patients with idiopathic granulomatous anterior uveitis and a group of control subjects were included. The presence of anti-H. pylori IgG antibodies was determined. The chi-square test was performed for comparative analysis with GraphPad Prism V5.0 software. RESULTS: Thirty patients with idiopathic non-granulomatous anterior uveitis and 35 control subjects were included. In the determination of anti-H. pylori IgG antibodies, 24 (80%) patients and 19 (54%) control subjects were positive. A significant difference (p = 0.0263) was found between the groups and an odds ratio (OR) of 3.37. CONCLUSIONS: A direct relationship was found between the presence of anti-H. pylori IgG antibodies and idiopathic non-granulomatous anterior uveitis. An association can be established between idiopathic non-granulomatous anterior uveitis and H. pylori infection, without this being a causal or physiopathogenic relationship.


Subject(s)
Helicobacter Infections , Helicobacter pylori , Uveitis, Anterior , Humans , Prospective Studies , Cross-Sectional Studies , Antibodies, Bacterial , Acute Disease , Immunoglobulin G
3.
J Neuroimmunol ; 375: 578018, 2023 02 15.
Article in English | MEDLINE | ID: mdl-36657373

ABSTRACT

Our objective was to determine whether (-)-Epicatechin administered alone or simultaneously with topical Ketorolac decreased the relative expression of GFAP and modulated the response of Nrf2 in a mouse model with induced hyperglycemia. We found that GFAP and Nrf2 decreased in the groups that received treatments alone or simultaneous during 8 weeks; even when the effect on the Nrf2 was not pronounced, it showed a higher concentration when GFAP decreased. Our results suggest a protective effect of Ketorolac and (-) - Epicatechin, which seem to limit the preclinical retinal damage caused by inflammation in hyperglycemia.


Subject(s)
Catechin , Hyperglycemia , Retinal Diseases , Animals , Mice , Catechin/pharmacology , Catechin/therapeutic use , Catechin/metabolism , Hyperglycemia/drug therapy , Hyperglycemia/metabolism , Ketorolac/therapeutic use , Ketorolac/metabolism , Ketorolac/pharmacology , Mice, Inbred C57BL , NF-E2-Related Factor 2/metabolism , NF-E2-Related Factor 2/pharmacology , Retina/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...